.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
UBS
Daiichi Sankyo
Queensland Health
Fish and Richardson
Merck
Cerilliant
Federal Trade Commission
Dow
Chubb

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205435

« Back to Dashboard
NDA 205435 describes SIVEXTRO, which is a drug marketed by Cubist Pharms Llc and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the SIVEXTRO profile page.

The generic ingredient in SIVEXTRO is tedizolid phosphate. One supplier is listed for this compound. Additional details are available on the tedizolid phosphate profile page.

Summary for NDA: 205435

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:3

Pharmacology for NDA: 205435

Suppliers and Packaging for NDA: 205435

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SIVEXTRO
tedizolid phosphate
TABLET;ORAL 205435 NDA Merck Sharp & Dohme Corp. 67919-041 67919-041-01 30 TABLET, FILM COATED in 1 BOTTLE (67919-041-01)
SIVEXTRO
tedizolid phosphate
TABLET;ORAL 205435 NDA Merck Sharp & Dohme Corp. 67919-041 67919-041-02 1 BLISTER PACK in 1 CARTON (67919-041-02) > 6 TABLET, FILM COATED in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Jun 20, 2014TE:RLD:Yes
Regulatory Exclusivity Expiration:Jun 20, 2024
Regulatory Exclusivity Use:GENERATING ANTIBIOTIC INCENTIVES NOW
Regulatory Exclusivity Expiration:Jun 20, 2019
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:► SubscribePatent Expiration:Feb 23, 2028Product Flag?YSubstance Flag?YDelist Request?
Patented Use:METHOD OF TREATING BACTERIAL INFECTIONS


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
Express Scripts
Dow
Johnson and Johnson
Merck
Cerilliant
Cantor Fitzgerald
McKesson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot